IFN-α-2b Reduces Postoperative Arthrofibrosis in Rats by Inhibiting Fibroblast Proliferation and Migration through

Zhendong Liu1,2, Zhehao Fan1, Rui Wang2

  • 1Clinical Medical College of Yangzhou University, Subei People's Hospital of Jiangsu Province, Yangzhou 225001, China.

Abstract

Insights

Interferon alfa-2b (IFN-α-2b) effectively prevents arthrofibrosis after knee surgery in rats by inhibiting fibroblast proliferation and migration. This therapeutic effect may involve the STAT1/p21 signaling pathway.

Area of Science:

  • Orthopedics
  • Immunology
  • Cell Biology

Background:

  • Postoperative arthrofibrosis is a significant complication following knee surgery.
  • Fibroblast proliferation and migration are key contributors to scar tissue formation and joint stiffness.

Purpose of the Study:

  • To evaluate the efficacy of Interferon alfa-2b (IFN-α-2b) in preventing arthrofibrosis in a rat model.
  • To investigate the in vitro anti-proliferative effects of IFN-α-2b on fibroblasts.
  • To elucidate the molecular mechanisms underlying IFN-α-2b's action.

Main Methods:

  • Establishment of a rat model for post-surgical arthrofibrosis.
  • Histological and immunohistochemical analysis of knee joint tissues.
  • In vitro assays including CCK-8, EdU, wound healing, and Transwell migration assays.
  • Western blotting and database analysis to explore molecular pathways.

Main Results:

  • IFN-α-2b treatment significantly reduced arthrofibrosis in rats, decreasing fibroblast numbers and collagen expression.
  • In vitro studies confirmed that IFN-α-2b inhibits fibroblast proliferation and migration.
  • Database analysis and experimental validation suggest the involvement of the STAT1/p21 signaling pathway.

Conclusions:

  • IFN-α-2b demonstrates potential as a therapeutic agent for preventing surgery-induced arthrofibrosis.
  • The mechanism of action involves the inhibition of fibroblast activity.
  • Regulation of the STAT1/p21 signaling pathway is implicated in IFN-α-2b's anti-arthrofibrotic effects.